Cumberland Pharmaceuticals Inc.
CPIX
Market Cap$17.62M
Close$
$10.05
294% upside
Current Fair Value
294% upsideUndervalued by 294% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.62 Million |
|---|---|
| Enterprise Value | $26.88 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.44 |
| Beta | 0.2 |
| Outstanding Shares | 14,118,091 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.7 |
|---|---|
| PEG | 1.03 |
| Price to Sales | 1.28 |
| Price to Book Ratio | 1.28 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | -7.27 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | 0.85 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cumberland Pharmaceuticals Inc.
90 employeesCumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and produ...